Philip Morris
Big Dose of Research, But Still No Cure
Fields
- Author
- Greve, F.
- Type
- NEWS, NEWS ARTICLE
- Document File
- 2025823308/2025823718/Social Costs - File 1
- Area
- POTTORFF,MARY/FILE ROOM ANNEX
- Named Organization
- American Industrial
- Congress
- Cpsc, Consumer Products Safety Commission
- Epa, Environmental Protection Agency
- FDA, Food and Drug Administration
- in Univ
- Natl Space + Aerpnautics Administration
- NCI, Natl Cancer Inst
- OSHA, Occupational Safety & Health Administration
- White House
- American Cancer Society
- Congress
- Site
- N412
- Named Person
- Bobst, E.
- Califano, J.
- Carter
- Farber, S.
- Hornback, N.
- Kennedy, D.
- Landers, A.
- Nixon, R.
- Pollard, H.M.
- Rauscher, F.
- Saffiotti, U.
- Upton
- Upton, A.
- Watson, J.
- Williams, C.M.
- Zinder, N.
- Califano, J.
- Request
- Stmn/R1-072
- Stmn/R1-073
- Author (Organization)
- Miami Herald
- Litigation
- Stmn/Produced
- Date Loaded
- 05 Jun 1998
- UCSF Legacy ID
- arz83e00
Document Images
Mostly sunny tQdayi purt-' ~
ly" cloudy Monday. Highs In
th_~ low to mid-80s. Lows
mostly low 70s. (Details,
Page 2A.)
SATURDAY'S TEMPERATURES,
7 n.m. cB Noon ea c p
m 7n
.
~ a.m. 70 2 p.m. H1 I E p.nt 76 ,10 a.m.76 , 1 p.m, 80 10 p.m)6 .. .
D
®
. :1''ir0l Gf'a: ,tieYieB
I3y hRANK GftEVC
. nerald Wa~hlnqion Dur.au .
WASHINGTON, - Only elght,
years ago, Congress was so optimis-
tic abou4 ctring cancer that it or-
dered "a national cancer crusade to
I
~,
. .
j Copyriph('D1971 Tht Mlnml R.rald,;
ing 'warnings that' saccharin, eggs,, "cured" 'from '.1950-59 to 4b; per
barbecued meats and promiscuity . cent for 1967-73.
may cause cancer. But the body count bnsedbn rhor-',
.As for the frontal assault against 'tality is even less encouraging.-In.:
smoking, 22 years of battle haven't 1950,.125 persons hi every 100;000--
appreciably weakened the tobacco .'died of cancer, In 1975 the number
industry, and soaring lung cancer was 131. '
rates have all but wiped out gains - The tripling since 1950' of
limg
~
be accomplished by 1976 as an ap-. :' a against other forms of the disGase. ' cancer; one of the
leust;.curable '
propriate commemoration of the toward conquering this dread dis- , conceded ' - Dr. ' Donald
Kennedy, ,. forms of the disease, distorts these .;
200th anniversary of the, Indepen- ease." Nixon declared. . commissioner df~the Food -and Drug
EVEN THE "body count" in the statistics and understates -the'treal
dence of our country.", . , Today, $4.7 billion later, the can-1 Administration: : ' cancer war is
debated. The Ameri-. . but limited pl-ogress that has been..,
President Richard Nixon, acting cer crusade seems less like a moon= . The search for a "magic
bullet" . can Cancer Society (ACS), which made, cancer researchers polntout. :
upon thttt optimism in his 1971 shot and more like. the- Vietnam. drug cure that would make cancer,
likes to emphasize progress, mea-- They also argue that comparing `,
State of the Union address, added v,ar: 'I'he enemy has protfed more go the way of polio has ended
with' sures'success by five-year survival' the wat on catlcer to Vietnam Is un-'t.
$100 million to tile 1972 budget for. t.vlly than expected, and,scientific' the acknowledgement that
cancer is ~'rates. If a victim Is alive and symp- fair - that the United States spent ~
cancer research and promised more. .researchers{ess scientific. I a family of more than 100
diseases, tom-free five years after cancer is .$118 billion in Indochina, but only
"The time has conte in America. I ,. , , ., -. ; ' , : each distinctive enough to defy any'
detected, the cancer society consjd- $7 billion; since 1967, on ctlncer
when the same sort of concentrated PREDICTABLY, ,"'['he , more{'sin6letreatmente ers him cured. And
the body count, they say,.also '
effort that~spiit the atom and took money we spend, the more complex :. Headlines promising break-'"
;);ven by this,neasure progress Is.' is noncomparable: 46,370 Ameri- --
man to the moon should be turned 'the problem (seems) to , appear,":, throughs have given way to
confus- achingly slow. -= front 39.per cent cans died in 14 years of Vietnam,.'
'.
:346.:Pzig,es 1.,
.
.
I'I (ll-i'l~r.'s Coni:Plete 1lfetospaPer,..
.~ ~ /l Lntln Amcrlcan l=dltlon IS Publlahed Dally

Tilt C Wil p',K .
-, l. 0-'1'~.~a r . cat,s(:".::.
National Cancer Institute .
Appropriations
1969
..1970
1971:r,.
1972
1973 ,
1 974- ~
1975-'
1976 ,
1977'
1978, :
$185 million
$190-million
$230 million
$379million
$492 million
$551 million
''.$692 million
$762 million
~
$815 million
'(estimated) ,
,. $867.million
wh(le 382,000 Amerlcans died of
cancer last year alone. : .
NL'VLRTIiLLL.SS, this ,Isn't'the
Turn to Page 20A Col. 1., .'
~.; ~__ ------ ----- -----
FffOM PAGE I A
kind of news that taxpayers and
contributors to the cancer society
paid to hear. In response, Congress
has cut the once lavish flow of
money to anti-cancer agencies to a
cautious, cost-of-living-increase
trickle. Investigative hearings are
expected later this year into the op-
<rations of the National Cancer In-
stitute (NCI), thC' leading federal
,rgency in the cancer war.
Even the basic strategy of fight-
ing cancer by concentrating on cure
and treatment is under challenge.
Growing numbers of scientists
and congressmen want major new
emphasis on preventing cancer by
lighlcr control on environmental
and workplace pollutants, smoking,
diet and anything else that may
cause the disease.
Others say this idea is a folly,
bred of iiupatieuce, and likely to
pro~e tlte inost expensive boondog-
gle of the Lrusade-
11tEANW1ilt.E, everyone admits
the dream of conquering cancer
witlr a big fast dose of biomedical
research was naive and unfortu-
nate.
VGS(.C.99CaVZ
"Inevitably, the new, major ini-
tiatives by the White Ilouse and
Congress carried with them the
dangers of overexpectancy and ov-
erpromise," conceded Dr, Frank
Rauscher, former director of the
National Cancer Institute and now
senior vice president of the Ameri-
can Cancer Society.
Although the cancer society
would like to claim it played no
part in overselling the curability of
cancer to Congress, Nixon and the
public, that's simply untrue. The
former president was goaded In a
widely reprinted full-page netvspa-
per ad in 1969 that proclaimed:
"Mr. Nixou: You can cure cancer."
It quoted Dr. Sidney Farber, past
president of the cancer society:
"We are so close to a cure for can-
cer. We lack only the kind of
money and comprehensive planning
that went into putting a man on the
moon."
IN 1971, cancer 'society President
Dr. li. Marvin Pollard used the
same moonshot analogy at a con-
vention of science writers. It even
turned up in Ann Landers' advice
column.
"If this great country of ours can
put a man on the moon, why can't
we find a cure for cancer?" Landers
asked rhetorically in April 1971, as
the landmark Cancer Act was being
debated in Congress. Warning that
"the funds designated for medical
research in America are grossly in-
adequate," Landers, a member 'of
the cancer society, urged her read-
ers "to play, your part" by writing
their senators in support of the war
against the disease.
When Nixon pitched for cancer'
research in his State of the Union
message, he acted at the urging of
pharmaceuticals titan Elmer Bobst,
a $63,000 contributor to the Nixon
campaign and former chairman of
the cancer society. The'reason be-
hind the pressure was that Nixon
had cut cancer research funds by
three per cenl in 1970.-
Ignored in tlie drum-beating for a
cancer cure were cell research sci-
entists, like Nobel laureate James
Watson, who warned that scientists
knew too little about how" normal
cells work to try to understand and
kill abnormal cancer cells.
Using everyone's favorite space
simile, Watson likened the cancer
crusade to "trying to put a man on
the moon in 1920 before missiles
were invented ... (by giving) con-
tracts to cannon manufacturers,"
ladder builders, and many, many
administrators ... but (with) no
support for missile research."
SUCII OBJECTIONS were dis-
missed at the time as jealous nega-
tivism, and Congress eagerly en-
dorsed the National Cancer Act of.
1971. Hustled through the White
House by Dec. 23, in time for pre-
sentation as a natibnal Christmas
gift, the act made the National Can-
cer Institute something like the Na-
tional Aeronautics and Space Ad-
ministration (NASA) - a goal-ori-
ented agency responsible directly to
the president.
As it turned out, Nixon never got
much credit for leading the cancer
crusade because Congress always
increased the big cancer institute
budget increases lie proposed.
With the generosity came pres-
sure for results. By definition, that
meant a cure for cancer, either a
vaccine that would prevent the dis-
ease or a treatment that would stop
it cold.
In the early 1970s, many scien-
tists believed cancer was caused by
viruses altering cells. So the biggest'
grants went to research on viruses,
more than $400 million to date.
BUT TODAY few scientists think
viruses cause cancer in humans.
A 1974 investigation of the viral
research program reached the same
conclusion that Watson had prediot-
ed: So little is known about how
cells work that "it is difficult to be-
certain where to begin, much less
_organize a focused attack," '
The writer, Dr. Norton Zinder, a
Rockefeller University virologist,
disclosed another effect of the sud-
den, massive funding: Research
management at the National Cancer
Institute had gone ltaywire-
Zinder and his investigators
found that cancer institute scien-
tists "tended to delegate study of
scientific problems to friendly col-
leagues." Review of contracts was
characterized as "a farce." Specifi-
cally, "no hard questions were
asked about the scientific contents
of the proposal, the past productivi-
ty of the contractor or the program
relevance. The budget was not even
tnrnlinn rl, lot alone an,tlyzed."
found that some cancer institute
scientists single-handedly had pro-
posed, reviewed and approved con-
tracts for assistance on their own
projects by outside researchers who
were close friends. Dr. Zinder
deemed the practice "embarrassing,
if not illegal."
Cluntly speaking, Zinder was
suggesting that conflicts of interest
abounded in cancer research.
Dr. Arthur Upton, appointed di-
rector of the institute by Pt-esident
Carter, conceded it is still possible
for an NCI scientist "to arrange a
contract to support his buddies, if
you will, and at the same lime ex-
tend his own research operation."
Dr. Upton said lie is putting a stop
to the practice, as well as winding-
down virus research, which is still
costing about $100 million a year.
RCSEARCH boondoggles weren't
the only problem created for the
Natioual Cancer Institute 'by the
crusad.e windfall. Under the Cancer
~ Act, the research-oriented institute
had to develop 19 regional compre-
hensive cancer centers. The centers,
popular with Congress, were to
provide the best cancer treatment
possible all across the country, to
stress research in drug, radiology
and surgical treatments, and to pro-
mote any advances throughout the'
medical World.
As they have evolved, these re-
gional centers have much to do
with treating cancer patients but
little to do with cure-oriented re-
search or prevention. This year,
they will cost the cancer institute
more than $170 million, an expense
that has provoked an angry rivalry
between basic researchers and can-
cer doctors.
Dr. Carrol M. Williams, a l-Iar-
vard biologist, gives one side of the
argument, his excess fueled by his
passion: "The money spent for just
one tenuinal cancer (patient) today
could fund a whole laboratory's re-
search into the real fundamental
questions we must answer before
we can make any measureable
progress against cancer."
T1IL OTHER half of the argu-
ment conies from Dr. Ned I torn-
back, chairman of the Cancer Radi-
ation Department at Indiana Uni-
versity Medical School: "What do
( W\ ca~- c
r
~

we do with the cancer patients
now, tell them to come back in 20
years when we have a cure? Tell
them not to bother us because we're
busy in tbe lab?"
These two urgent priorities,
treatment and cure, still dominate
the philosophy - and the budget =
of the National Cancer Institute.
They all but squeeze out the agen-
cy's third mission: the prevention of
cancer.
If the cancer crusade loses,its sta-
lus as a holy war, it will happen on
the prevention battlefield. Cure and
treatment have no enemies, preven-
Lion has plenty of them. _
ON ONE hand, tobacco interests
stoutly resist efforts to make people
stop smoking, though most re-
searchers outside the tobacco indus-
try say smoking is linked to 35 to
40 per cent of all cancer deaths. '
On the other hand, wheq cancer
crusaders attack industrial polluters
and food processors, their evidence
is weaker. The research linking
specific food additives and pollu-
tants to cancer is far less convinc-
ing than tite research indicating
that smoking causes cancer.
Nonetheless, the prevention bat-
tle is on. Joseph Califano, Secretary
of liealth, Education and Welfare
(IIEW), signalled that in January
when lie declared war on smoking_
In the coming months, regulatory
agencies will propose tighter re-
strictions on all industrial chemicals
and pollutants suspccted of being
cancer-causers. The Food and Drug
Administration is expected to fol-
low suit on food additives and
drugs.
DESPITE the lack of absolute
proof, many scientists agree with
federal regulators who today say
that most human cancer is environ-
mentally related, a tricky term that
extends to cigaret smoking and die-
iary factors.
The theory is, as Dr. Upton of the
National Cancer Institute puts it,
that "the human population is ex-
posed to a sea of carcinogenic fac-
tors, acting in combination - most
of them weak carcinogens, but act-
ing in complicated mixtures." ~
009eq%V85% 0%
Lacking 'good evidence "that
there's a zero-risk level of safe ex-
posure," Upton continued, "the pru-
dent posture is to reduce the level
of exposure wherever possible."
Regulators at the Occupational
Safety and Health Administration
OStIA ~ the Environmental Protec-
) .-----
tion Agency (EP)k),' and the Con-
sumer Product Safety Commission
(CPSC) want to do just that. They
propose a new system of uniform
-tests, risk classification and expo-
sure limits for at least 258 common-
ly used chemicals suspected of
being the most potent cancer-caus-
ers. i ~ '
APPALLED BY the potential eco-
nomic impact on their business,
more than 250 industries and trade
associations have submitted briefs
opposing the first such major pro-
posal. Ninety of the biggest firms,
mostly chemical manufacturers,
have contributed more than $1 mil-
lion to fight the regulations through
a new association, the American In-
dustrial Health Council.
If the regulators go into battle
with insufficient evidence, it's part-
ly due to the low priority historical-
ly given cancer prevention at the
National Cancer Institute. The insti-
tute has fewer than a dozen skilled
epidemiologists, and bioassay re-
search has serious manpower prob-
. .
lems too. -
In a, 1976 resignation letter, Dr.
Umberto Saffiotti, ' head of the
bioassay project at the cancer insti-
tute, wrote: -
"There are now over 200 (experi-
mental) results still waiting to be
reviewed and published, while no
substantial supportive staff is pro-
vided ... I cannot accept any longer
a situation which in fact deprives
the regulatory agencies, industry,
labor, consumers and the scientific
community of data of urgent public
health value."
SINCE Saffiottti's resignation,
the cancer institute has sought to
speed the release of bioassay results
through a committee of researchers,
public health scientists and industry
experts on occupational safety.
About 100 cases in the backlog have
been cleared for release.
When regulatory hearings begin
in May, the tobacco industry will
side with the government in favor
of tighter control of industrial can-
cer causers. Other industries will
counter that if the governnient goes
after their products, it will neglect
the larger, proven hazard of tobac-
co. ..
So the question becomgs: What
has the National Cancer Institute,
as the government's main anti-can-
cer agency, done about smoking?
"The ACS and the NCI have both
done as much as they could," said
Dr. Rauscher, who has served as a
toj) executive in both organization.
Once the agencies established the
link between smoking and cancer,
he said, it was up to the public to
"either accept the data or reject it."
(NEXT: As the American Cancer
Society goes, so goes the federal
cancer war. Why? '
I
